The tellurium‐based immunomodulator, AS101 ameliorates adjuvant‐induced arthritis in rats

Despite undeniable improvement in the management of rheumatoid arthritis (RA), the discovery of more effective, less toxic and, ideally, less immune suppressive drugs are much needed. In the current study, we set to explore the potential anti‐rheumatic activity of the non‐toxic, tellurium‐based immu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Exp Immunol
Autors principals: Halpert, G., Halperin Sheinfeld, M., Monteran, L., Sharif, K., Volkov, A., Nadler, R., Schlesinger, A., Barshak, I., Kalechman, Y., Blank, M., Shoenfeld, Y., Amital, H.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7874835/
https://ncbi.nlm.nih.gov/pubmed/33205391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13553
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars